R. Sylvester
European Urology · 2000–2021
A researcher in the Science corpus: 23 papers; trusts 0 researchers and is trusted by 6 researchers here, as inferred from the citation graph.
Who trusts R. Sylvester overall
Papers from R. Sylvester's perspective
Ordered by how strongly the researchers R. Sylvester trusts endorse each paper. Same corpus, a different order for every researcher.
- Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. (Journal of Urology)
- Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors
- Association between smoking and risk of bladder cancer among men and women (Journal of the American Medical Association (JAMA))
- Epidemiology and risk factors of urothelial bladder cancer. (European Urology)
- Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model. (Journal of Urology)
- WHO Classification of of Tumours of the Urinary System and Male Genital Organs
- Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration (Cancer)
- Going from evidence to recommendations (British medical journal)
- The present and future burden of urinary bladder cancer in the world (World journal of urology)
- Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. (Journal of Urology)
Their papers
- European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ). (2021) — 1,354 citations
- EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. (2017) — 1,994 citations
- EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin. (2016) — 618 citations
- European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update. (2015) — 837 citations
- EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. (2013) — 1,775 citations
- Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986. (2012) — 706 citations
- A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. (2011) — 807 citations
- International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial. (2011) — 842 citations
- EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. (2011) — 735 citations
- Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. (2009) — 711 citations
- EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. (2008) — 800 citations
- A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. (2007) — 762 citations
- Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. (2006) — 1,048 citations
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. (2005) — 7,387 citations
- Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis. (2005) — 882 citations
- A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. (2004) — 737 citations
- Prognostic factors for survival in adult patients with cerebral low-grade glioma. (2002) — 874 citations
- Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. (2002) — 3,179 citations
- Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. (2002) — 675 citations
- Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. (2002) — 1,247 citations